Health-related quality of life for patients with metastatic pancreatic cancer: Updates from ESMO...

Prof Eric Van Cutsem (University of Leuven, Leuven, Belgium) and Dr Teresa Macarulla (Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain) discuss the latest updates presented at ESMO 2019 in pancreatic cancer. Prof Van Cutsem and Dr Macarulla discuss the recent advances in the neoadjuvant and adjuvant setting, including recent data from the APACT and NEOLAP studies. Dr Macarulla provides an overview of the POLO trial and reveals that quality of life is maintained during maintenance treatment w